Evidence map›Paper›PMID 39926073›Full record

ReviewJMA journal2025

Artificial Intelligence Applications in Ophthalmology.

Tetsuro Oshika

Abstract readReview
In one paragraph

Review in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tetsuro OshikaDepartment of Ophthalmology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ophthalmology is well suited for the integration of artificial intelligence (AI) owing to its reliance on various imaging modalities, such as anterior segment photography, fundus photography, and optical coherence tomography (OCT), which generate large volumes of high-resolution digital images. These images provide rich datasets for training AI algorithms, which enables precise diagnosis and monitoring of various ocular conditions. Retinal disease management heavily relies on image recognition. Limited access to ophthalmologists in underdeveloped areas and high image volumes in developed countries make AI a promising, cost-effective solution for screening and diagnosis. In corneal diseases, differential diagnosis is critical yet challenging because of the wide range of potential etiologies. AI and diagnostic technologies offer promise for improving the accuracy and speed of these diagnoses, including the differentiation between infectious and noninfectious conditions. Smartphone imaging coupled with AI technology can advance the diagnosis of anterior segment diseases, democratizing access to eye care and providing rapid and reliable diagnostic results. Other potential areas for AI applications include cataract and vitreous surgeries as well as the use of generative AI in training ophthalmologists. While AI offers substantial benefits, challenges remain, including the need for high-quality images, accurate manual annotations, patient heterogeneity considerations, and the "black-box phenomenon". Addressing these issues is crucial for enhancing the effectiveness of AI and ensuring its successful integration into clinical practice. AI is poised to transform ophthalmology by increasing diagnostic accuracy, optimizing treatment strategies, and improving patient care, particularly in high-risk or underserved populations.

Indexed as

Anterior segment diseasesArtificial intelligenceDeep learningRetinal diseasesSmartphone

Identifiers

PMID39926073
PMCPMC11799668

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.